Michael P Lisanti
Overview
Explore the profile of Michael P Lisanti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
422
Citations
28904
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Brindisi M, Frattaruolo L, Fiorillo M, Dolce V, Sotgia F, Lisanti M, et al.
FEBS J
. 2022 Oct;
290(6):1481-1501.
PMID: 36237175
Breast cancer remains the greatest cause of cancer-related death in women worldwide. Its aggressiveness and progression derive from intricate processes that occur simultaneously both within the tumour itself and in...
12.
Fiorillo M, Ozsvari B, Sotgia F, Lisanti M
Front Oncol
. 2021 Nov;
11:740720.
PMID: 34722292
Recently, we presented evidence that high mitochondrial ATP production is a new therapeutic target for cancer treatment. Using ATP as a biomarker, we isolated the "metabolically fittest" cancer cells from...
13.
Sargiacomo C, Stonehouse S, Moftakhar Z, Sotgia F, Lisanti M
Front Oncol
. 2021 Aug;
11:678343.
PMID: 34395247
MitoTracker Deep Red (MTDR) is a relatively non-toxic, carbocyanine-based, far-red, fluorescent probe that is routinely used to chemically mark and visualize mitochondria in living cells. Previously, we used MTDR at...
14.
Di Pisa F, Pesenti E, Bono M, Mazzarello A, Bernardi C, Lisanti M, et al.
BMC Mol Cell Biol
. 2021 Aug;
22(1):41.
PMID: 34380438
Background: The human SH3 domain Binding Glutamic acid Rich Like 3 (SH3BGRL3) gene is highly conserved in phylogeny and widely expressed in human tissues. However, its function is largely undetermined....
15.
Fiorillo M, Scatena C, Naccarato A, Sotgia F, Lisanti M
Cell Death Differ
. 2021 May;
28(9):2797-2817.
PMID: 33986463
Here, we provide evidence that high ATP production by the mitochondrial ATP-synthase is a new therapeutic target for anticancer therapy, especially for preventing tumor progression. More specifically, we isolated a...
16.
New insights in the expression of stromal caveolin 1 in breast cancer spread to axillary lymph nodes
Scatena C, Fanelli G, Fanelli G, Menicagli M, Aretini P, Ortenzi V, et al.
Sci Rep
. 2021 Feb;
11(1):2755.
PMID: 33531603
Recent evidence suggests that a loss of expression of caveolin in the stromal compartment (sCav-1) of human invasive breast carcinoma (IBC) may be a predictor of disease recurrence, metastasis and...
17.
Sanchez-Alvarez R, De Francesco E, Fiorillo M, Sotgia F, Lisanti M
Front Oncol
. 2020 Nov;
10:1776.
PMID: 33194575
Elevated mitochondrial biogenesis and metabolism represent key features of breast cancer stem cells (CSCs), whose propagation is conducive to disease onset and progression. Therefore, interfering with mitochondria biology and function...
18.
Sotgia F, Lisanti M
Aging (Albany NY)
. 2020 Oct;
12(19):18797-18803.
PMID: 33049711
Three recent papers published in Nature, Science and Cell, all present clear evidence that there is cross-reactive T-cell immunity between human coronaviruses (229E, NL63, OC43, and HKU1), linked with the...
19.
Ozsvari B, Magalhaes L, Latimer J, Kangasmetsa J, Sotgia F, Lisanti M
Front Oncol
. 2020 Oct;
10:1528.
PMID: 33042796
Here, we describe the chemical synthesis and biological activity of a new Doxycycline derivative, designed specifically to more effectively target cancer stem cells (CSCs). In this analog, a myristic acid...
20.
Chen K, Jiao X, Ashton A, Di Rocco A, Pestell T, Sun Y, et al.
Oncogenesis
. 2020 Sep;
9(9):83.
PMID: 32948740
The essential G-cyclin, CCND1, is a collaborative nuclear oncogene that is frequently overexpressed in cancer. D-type cyclins bind and activate CDK4 and CDK6 thereby contributing to G-S cell-cycle progression. In...